LTD4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Asthma, Pneumonia and Allergic asthma. The involved functions are known as inhibitors, Signal Transduction, Cell Survival, antagonists and Phosphorylation. Ltd4 often locates in Membrane, Tissue membrane, Protoplasm, Cytoplasmic matrix and membrane fraction. The associated genes with LTD4 are ALOX5 gene, UMOD gene, P4HTM gene, RAF1 gene and Homologous Gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of LTD4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTD4?

LTD4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Allergic asthma, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTD4

MeSH term MeSH ID Detail
Respiratory Hypersensitivity D012130 18 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Enteritis D004751 8 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Carotid Stenosis D016893 15 associated lipids
Influenza, Human D007251 11 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with LTD4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTD4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTD4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTD4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTD4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTD4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTD4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTD4

Download all related citations
Per page 10 20 50 100 | Total 640
Authors Title Published Journal PubMed Link
Suzuki R and Freed AN Heparin inhibits hyperventilation-induced late-phase hyperreactivity in dogs. 2002 Am. J. Respir. Crit. Care Med. pmid:11779726
Young RN Discovery of montelukast: a once-a-day oral antagonist of leukotriene D4 for the treatment of chronic asthma. 2001 Prog Med Chem pmid:11774796
Kawagishi Y et al. [Clinical significance of measurement of urinary leukotriene E4 in asthmatic patients without attack]. 2001 Arerugi pmid:11761885
Martin V et al. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors. 2001 Biochem. Pharmacol. pmid:11705452
Gauvreau GM et al. Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma. 2001 Am. J. Respir. Crit. Care Med. pmid:11704602
Ro JY et al. The inhibitory mechanism of rebamipide on the mediator release in the guinea pig lung mast cells activated with specific antigen-antibody reactions. 2001 Pharmacology pmid:11598424
Hui Y et al. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. 2001 J. Biol. Chem. pmid:11591709
Nishimura H et al. Acute effects of prostaglandin D2 to induce airflow obstruction and airway microvascular leakage in guinea pigs: role of thromboxane A2 receptors. 2001 Prostaglandins Other Lipid Mediat. pmid:11519790
Thivierge M et al. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. 2001 J. Immunol. pmid:11509632
Aoki M et al. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. 2001 J. Pharmacol. Exp. Ther. pmid:11504812
Bäck M et al. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea. 2001 Br. J. Pharmacol. pmid:11487525
Shi ZZ et al. Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response. 2001 Mol. Cell. Biol. pmid:11463821
Echazarreta AL et al. Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D(4) in asthma. 2001 Am. J. Respir. Crit. Care Med. pmid:11463588
Mizutani N et al. Markedly increased nasal blockage by intranasal leukotriene D4 in an experimental allergic rhinitis model: contribution of dilated mucosal blood vessels. 2001 Jpn. J. Pharmacol. pmid:11459119
Möhle R et al. Transendothelial migration of hematopoietic progenitor cells. Role of chemotactic factors. 2001 Ann. N. Y. Acad. Sci. pmid:11458515
Ruck LM et al. Synergistic antiallergic activity of combined histamine H1- and cysteinyl leukotriene1-receptor blockade in human bronchus. 2001 Life Sci. pmid:11432448
Karaman O et al. The comparison of the efficacy of fluticasone propionate with cetirizine in perennial allergic rhinitis. 2001 Mar-Apr Allergol Immunopathol (Madr) pmid:11420028
Nabe T et al. Comparison of cedar pollen-induced allergic rhinitis in passively and actively sensitized guinea pigs. 2001 Jpn. J. Pharmacol. pmid:11388645
Bouchelouche K et al. Cysteinyl-leukotriene D(4) receptors in smooth muscle cells. 2001 Urology pmid:11378074
Bouchelouche K et al. Calcium signaling in cultured human detrusor smooth muscle cells from patients with interstitial cystitis. 2001 Urology pmid:11378073
Bautz F et al. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1. 2001 Blood pmid:11369634
Snetkov VA et al. Mechanisms of leukotriene D4-induced constriction in human small bronchioles. 2001 Br. J. Pharmacol. pmid:11350860
Oliveira SH et al. SCF-induced airway hyperreactivity is dependent on leukotriene production. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11350804
Bouchelouche K et al. The action of cysteinyl-leukotrienes on intracellular calcium mobilization in human detrusor myocytes. 2001 BJU Int. pmid:11350414
Massoumi R and Sjölander A Leukotriene D(4) affects localisation of vinculin in intestinal epithelial cells via distinct tyrosine kinase and protein kinase C controlled events. 2001 J. Cell. Sci. pmid:11329379
Aoki M et al. Antiasthmatic effect of YM976, a novel PDE4 inhibitor, in guinea pigs. 2001 J. Pharmacol. Exp. Ther. pmid:11259541
Saegusa S et al. Leukotriene D(4)-induced Rho-mediated actin reorganization in human bronchial smooth muscle cells. 2001 Eur. J. Pharmacol. pmid:11226389
Maekawa A et al. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11226226
Tohda Y et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. 2001 Respiration pmid:11223734
Venugopal CS et al. Comparative responses of bronchial rings to mediators of airway hyperreactivity in healthy horses and those affected with summer pasture-associated obstructive pulmonary disease. 2001 Am. J. Vet. Res. pmid:11212036
Accomazzo MR et al. Leukotriene D4-induced activation of smooth-muscle cells from human bronchi is partly Ca2+-independent. 2001 Am. J. Respir. Crit. Care Med. pmid:11208655
Simons FE et al. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast. 2001 Ann. Allergy Asthma Immunol. pmid:11206237
Kivity S et al. Eosinophil influx into the airways in patients with exercise-induced asthma. 2000 Respir Med pmid:11192956
Mehta KA et al. Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix. 2001 Int J Pharm pmid:11165089
Hele DJ et al. Mediator involvement in antigen-induced bronchospasm and microvascular leakage in the airways of ovalbumin sensitized Brown Norway rats. 2001 Br. J. Pharmacol. pmid:11159698
Gronert K et al. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. 2001 Am. J. Pathol. pmid:11141472
Thodeti CK et al. The epsilon isoform of protein kinase C is involved in regulation of the LTD(4)-induced calcium signal in human intestinal epithelial cells. 2001 Exp. Cell Res. pmid:11139333
Campos MG et al. Galphimia glauca organic fraction antagonizes LTD(4)-induced contraction in guinea pig airways. 2001 J Ethnopharmacol pmid:11137344
Robbiani DF et al. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. 2000 Cell pmid:11114332
Hisamatsu K and Nakajima M Pranlukast protects leukotriene C4- and D4-induced epithelial cell impairment of the nasal mucosa in vitro. 2000 Life Sci. pmid:11105993
Nothacker HP et al. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. 2000 Mol. Pharmacol. pmid:11093801
Kalf GF Utility of a mouse model for studying the effects of benzene on the myeloid lineage: effects of hydroquinone on a model myeloid system. 2000 J. Toxicol. Environ. Health Part A pmid:11086946
Babu KS and Salvi SS Aspirin and asthma. 2000 Chest pmid:11083703
Thivierge M et al. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils. 2000 J. Immunol. pmid:11046055
Ohd JF et al. Leukotrienes induce cell-survival signaling in intestinal epithelial cells. 2000 Gastroenterology pmid:11040187
Ménard G and Bissonnette EY Priming of alveolar macrophages by leukotriene D(4): potentiation of inflammation. 2000 Am. J. Respir. Cell Mol. Biol. pmid:11017925
Kodani M et al. Intratracheal administration of anaphylatoxin C5a potentiates antigen-induced pulmonary reactions through the prolonged production of cysteinyl-leukotrienes. 2000 Immunopharmacology pmid:10996024
Titos E et al. Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis. 2000 Gastroenterology pmid:10982774
Bäck M et al. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes. 2000 Eur. J. Pharmacol. pmid:10936498
Bäck M et al. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes. 2000 Eur. J. Pharmacol. pmid:10936497